Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 9,434,000 | 10,115,000 | 10,536,000 | 9,844,000 | 9,312,000 |
| Cost of Goods | 3,049,000 | 3,471,000 | 3,409,000 | 3,578,000 | 3,572,000 |
| Gross Profit | 6,385,000 | 6,644,000 | 7,127,000 | 6,266,000 | 5,740,000 |
| Operating Expenses | 4,302,000 | 7,635,000 | 4,057,000 | 4,609,000 | 3,977,000 |
| Operating Income | 2,083,000 | -991,000 | 3,070,000 | 1,657,000 | 1,763,000 |
| Other Income | -80,000 | -365,000 | -183,000 | -153,000 | -139,000 |
| Pre-tax Income | 2,003,000 | -1,356,000 | 2,887,000 | 1,504,000 | 1,624,000 |
| Income Tax | 447,000 | -770,000 | 699,000 | 295,000 | 494,000 |
| Net Income Continuous | 1,556,000 | -586,000 | 2,188,000 | 1,209,000 | 1,130,000 |
| Minority Interests | 5,000 | 8,000 | 4,000 | 4,000 | 5,000 |
| Net Income | $1,551,000 | $-594,000 | $2,184,000 | $1,205,000 | $1,125,000 |
| EPS Basic Total Ops | 0.56 | -0.22 | 0.79 | 0.44 | 0.41 |
| EPS Basic Continuous Ops | 0.57 | -0.21 | 0.79 | 0.44 | 0.41 |
| EPS Diluted Total Ops | 0.56 | -0.20 | 0.78 | 0.43 | 0.40 |
| EPS Diluted Continuous Ops | 0.56 | -0.21 | 0.79 | 0.43 | 0.40 |
| EBITDA(a) | $3,276,000 | $194,000 | $4,245,000 | $3,207,000 | $3,324,000 |